Conversion Labs appoints medical advisory board member
Dr. Jeff Toll, a physician and online health and wellness influencer, has been appointed to the medical advisory board at Conversion Labs, a telemedicine and wellness company.
Vaxart names CEO
Andrei Floroiu has been named chief executive officer at Vaxart, a clinical-stage vaccine company. He joins the company as it continues to develop a potential COVID-19 vaccine. Previously, Floroiu held executive roles at Agenus, an immuno-oncology and vaccine company.
RareiTi appoints CEO
Alex Evans has been appointed chief executive officer of RareiTi, a managed access platform company. Previously, she held clinical and commercial roles at AstraZeneca and Biogen.
Resurgens Orthopaedics appoints CEO
Alex Bateman was named chief executive officer of orthopaedics practice Resurgens Orthopaedics. Previously, he held leadership positions at United Surgical Partners and DaVita.
FerGene names three leaders
Newly established biotech FerGene has named Ambaw Bellete its chief operating officer, Vijay Kasturi VP of medical affairs and Peter Olagunju SVP of technical operations. The gene therapy company was launched last year.
The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at email@example.com.